497: Definitive materials filed under paragraph (a), (b), (c), (d), (e) or (f) of Securities Act Rule 497
Published on February 21, 2007
Filed Pursuant to Rule 497
Registration Statement Nos. 333-138418 and 333-140735
PROSPECTUS
4,200,000 Shares
Common
Stock
We are a specialty finance company that provides customized
financing solutions to lower middle market companies located
throughout the United States, with an emphasis on the Southeast.
Our investment objective is to seek attractive returns by
generating current income from our debt investments and capital
appreciation from our equity related investments. We are an
internally managed closed-end, non-diversified investment
company that has elected to be treated as a business development
company under the Investment Company Act of 1940. Upon
completion of the formation transactions described in this
prospectus, we will acquire Triangle Mezzanine Fund LLLP, a
North Carolina limited liability limited partnership which is
licensed as a small business investment company by the United
States Small Business Administration. We will operate Triangle
Mezzanine Fund LLLP as a wholly-owned subsidiary and initially
will make all of our portfolio investments through that entity.
We are offering 4,200,000 shares of our common stock. This
is our initial public offering, and no public market currently
exists for our shares. Our common stock has been approved for
quotation on the Nasdaq Global Market under the symbol
TCAP.
Effective concurrently with the closing of this offering, we
will issue 1,416,667 shares of common stock, having an
aggregate value based on the initial public offering price of
$21.3 million, to the limited partners of Triangle
Mezzanine Fund LLLP in exchange for their limited partnership
interests. We will also issue an aggregate of
500,000 shares of our common stock, having an aggregate
value of $7.5 million, to the members of the general
partner of Triangle Mezzanine Fund LLLP in exchange for the
general partnership interest in Triangle Mezzanine Fund LLLP.
The general partnership interest acquired will have no value for
purposes of determining our net asset value. The
1,916,667 shares of common stock we will issue will have an
aggregate value of $28.8 million based on the initial
public offering price, while our pro forma aggregate net asset
value as of September 30, 2006, assuming the exchange of
1,916,667 shares of common stock for all partnership
interests on that date, was $22.7 million. Our pro forma
as-adjusted net asset value per share as of September 30,
2006 assuming the acquisition of all the outstanding partnership
interests and consummation of this offering was
$80.0 million or approximately $13.07 per share.
Consequently, investors purchasing stock in this offering will
incur immediate dilution of $1.93 per share. See
Dilution on page 34 for more information.
Investing in our common stock is speculative and involves
numerous risks, and you could lose your entire investment if any
of the risks occurs. Among these risks is the risk associated
with the use of leverage. For more information regarding these
risks, please see Risk Factors beginning on
page 12. Our shares have no history of trading in a public
securities market. Shares of closed-end investment companies
have in the past frequently traded at a discount to their net
asset value. If our shares trade at a discount to net asset
value, it may increase the risk of loss for purchasers in this
offering. This prospectus contains important information about
us that a prospective investor should know before investing in
our common stock. Please read this prospectus before investing,
and keep it for future reference.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or determined if this prospectus is truthful or
complete. Any representation to the contrary is a criminal
offense.
Per Share | Total | |||||||
Public offering price
|
$ | 15.00 | $ | 63,000,000 | ||||
Underwriting discount (sales load)
on 4,000,000 shares sold to public
|
$ | 1.05 | $ | 4,200,000 | ||||
Underwriting discount (sales load)
on 200,000 directed
shares(1)
|
$ | 0.375 | $ | 75,000 | ||||
Proceeds to us, before
expenses(2)
|
$ | 13.98 | $ | 58,725,000 |
(1) | The underwriters have reserved 200,000 shares of our common stock for sale to our directors, employees and their family members and associates, at the public offering price. | |
(2) | We estimate that we will incur approximately $1,500,000 of expenses in connection with this offering. |
We have granted the underwriters a
30-day
option to purchase up to an additional 630,000 shares of
our common stock at the public offering price, less the
underwriting discount (sales load), solely to cover
over-allotments, if any. If the over-allotment option is
exercised in full, the total public offering price would be
$72,450,000, the total underwriting discount (sales load) would
be $4,936,500, and the proceeds to us, before expenses, would be
$67,513,500.
The underwriters expect to deliver the shares on or about
February 21, 2007.
Morgan
Keegan & Company, Inc.
BB&T
Capital Markets
A
Division of Scott & Stringfellow, Inc.
Avondale
Partners
Sterne,
Agee & Leach, Inc.
The date of this prospectus is February 14, 2007.
UNDERWRITING
Under the terms and subject to the conditions contained in an
underwriting agreement dated February 14, 2007, the
underwriters named below, for whom Morgan Keegan &
Company, Inc. is acting as representative, have severally agreed
to purchase, and we have agreed to sell to them, the number of
shares of common stock indicated below:
Underwriter
|
Number of Shares | |||
Morgan Keegan & Company,
Inc.
|
2,100,000 | |||
BB&T Capital Markets, a
division of Scott & Stringfellow, Inc.
|
945,000 | |||
Avondale Partners, LLC
|
840,000 | |||
Sterne, Agee & Leach,
Inc.
|
315,000 | |||
Total
|
4,200,000 | |||
The underwriting agreement provides that the obligations of the
several underwriters to pay for and accept delivery of the
shares of common stock offered hereby are subject to the
approval of certain legal matters by their counsel and to
certain other conditions. The underwriters are severally
obligated to take and pay for all shares of common stock offered
hereby (other than those covered by the underwriters
over-allotment option described below) if any such shares are
taken. We have agreed to indemnify the underwriters against
certain liabilities, including liabilities under the Securities
Act.
Our common stock has been approved for listing on the Nasdaq
Global Market under the symbol TCAP.
Over-Allotment
Option
We have granted to the underwriters an option, exercisable for
30 days from the date of this prospectus, to purchase up to
an aggregate of 630,000 additional shares of common stock at the
public offering price set forth on the cover page hereof, less
underwriting discounts and commissions. The underwriters may
exercise this option solely for the purpose of covering
over-allotments, if any, made in connection with the offering of
the shares of common stock offered hereby. To the extent such
option is exercised, each underwriter will become obligated,
subject to certain conditions, to purchase approximately the
same percentage of such additional shares of common stock as the
number set forth next to such underwriters name in the
preceding table bears to the total number of shares set forth
next to the names of all underwriters in the preceding table.
Lock-Up
Agreements
We, and certain of our executive officers and directors, have
agreed, subject to certain exceptions, not to issue, sell, offer
to sell, contract or agree to sell, hypothecate, pledge,
transfer, grant any option to purchase, establish an open put
equivalent position or otherwise dispose of or agree to dispose
of directly or indirectly, any shares of our common stock, or
any securities convertible into or exercisable or exchangeable
for any shares of our common stock or any right to acquire
shares of our common stock, for a period of 365 days from
the effective date of this prospectus, subject to extension upon
material announcements or earnings releases. The representative,
at any time and without notice, may release all or any portion
of the common stock subject to the foregoing
lock-up
agreements.
Determination
Of Offering Price
Prior to the offering, there has been no public market for our
common stock. The initial public offering price was determined
by negotiation among the underwriters and us. The principal
factors considered in determining the public offering price
include the following:
| the information set forth in this prospectus and otherwise available to the underwriters, | |
| market conditions for initial public offerings, | |
| the history and the prospects for the industry in which we compete, |
88